Aug 10, 2026 06:44AM
Aug 5, 2026 05:38PM
May 6, 2026 04:07PM
Apr 16, 2026 08:06AM
Mar 4, 2026 06:43AM
Feb 26, 2026 01:07PM
Feb 24, 2026 07:05AM Vir Biotechnology (VIR) PT Raised to $18 at Needham
Feb 24, 2026 06:05AM
Feb 24, 2026 05:47AM
Feb 23, 2026 05:25PM
Feb 23, 2026 05:15PM
Feb 23, 2026 05:01PM
Jan 12, 2026 08:07AM
Dec 30, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR)
Dec 17, 2025 07:04AM
Dec 16, 2025 04:06PM
Dec 9, 2025 04:24AM
Nov 5, 2025 04:20PM
Oct 7, 2025 08:04AM
Sep 16, 2025 06:55AM
Sep 3, 2025 05:15AM Evercore ISI Starts Vir Biotechnology (VIR) at Outperform, PT $12
Aug 27, 2025 06:09AM
Aug 6, 2025 04:10PM
Aug 6, 2025 08:06AM
Jul 31, 2025 08:06AM
May 20, 2025 06:38AM
May 7, 2025 04:13PM
Mar 13, 2025 10:06AM Morgan Stanley Reiterates Overweight Rating on Vir Biotechnology (VIR)
Feb 26, 2025 04:14PM
Jan 30, 2025 07:54AM
Jan 9, 2025 04:25AM
Jan 8, 2025 04:01PM
Jan 8, 2025 01:27PM
Jan 8, 2025 11:18AM
Jan 8, 2025 07:46AM Vir Biotechnology Inc. (VIR) Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
Jan 8, 2025 07:46AM
Dec 12, 2024 04:07PM
Dec 2, 2024 04:41PM
Nov 20, 2024 07:51AM
Nov 18, 2024 04:06PM
Nov 15, 2024 11:00AM
Oct 31, 2024 04:10PM Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 51c
Oct 15, 2024 08:16AM
Sep 10, 2024 08:05AM
Sep 9, 2024 04:39PM
Sep 9, 2024 04:13PM
Aug 20, 2024 06:45AM
Aug 1, 2024 04:24PM
Aug 1, 2024 04:14PM Vir Biotechnology Inc. (VIR) Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cel
Aug 1, 2024 04:00PM

445,866 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All